Universitaetsklinikum Muenster

Münster, North Rhine-Westphalia 48149

3 studies enrolling now · 13 studies all time

What they study most

Age-related Macular Degeneration (AMD), Alzheimer's Disease, Arginase I Deficiency, Brain Edema, Chronic Cutaneous Lupus Erythematosus, Generalised Lipodystrophy, Geographic Atrophy (GA), Hyperargininemia, Leukemia, Myeloid, Acute, Lupus Erythematosus, Systemic, Lymphoma, Non-Hodgkin, Muscle Spasticity

Studies at this site

• A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy — Recruiting now
• MEASuRE: Metreleptin Effectiveness And Safety Registry — Recruiting now
• A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 — Completed
• A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Enrolling by invitation
• A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Running, not enrolling
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency — Completed
• A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia — Completed
• 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" — Completed
• An Adult Spasticity Registry of OnabotulinumtoxinA Treatment — Completed